F-group (family)
1075.1.1.1 ABC2_membrane
Ligands and drugs
930
Member domains
104
with ligand contacts (≤ 4 Å)
11.2% of members
71
with DrugDomain annotations
7.6% of members
61
with a DrugBank compound
6.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 1075.1.1.1 belongs to X-group 1075 Type II ABC exporter transmembrane domain fold, which binds 8.7 ligand superclasses per 20 proteins, broader than 72% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04540 | CLR | Cholesterol | 34 |
| DB00141 | NAG | N-Acetylglucosamine | 8 |
| DB01030 | TTC | Topotecan | 6 |
| DB06240 | R1H | Tariquidar | 6 |
| DB00171 | ATP | ATP | 5 |
| DB04327 | PEE | Phosphatidylethanolamine | 5 |
| DB01204 | MIX | Mitoxantrone | 4 |
| DB02777 | PLC | Diundecyl Phosphatidyl Choline | 4 |
| DB16829 | A8S | Abscisic Acid | 4 |
| DB16833 | ADP | Adenosine disphosphate | 3 |
| DB00619 | STI | Imatinib | 2 |
| DB04038 | ERG | Ergosterol | 2 |
| DB05482 | RS4 | SN-38 | 2 |
| DB04851 | — | — | 1 |
| DB08357 | P4G | Diethylene glycol diethyl ether | 1 |
| DB11995 | — | — | 1 |
| DB16407 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CLR | CHOLESTEROL | 42 |
| A8S | (2Z,4E)-5-[(1S)-1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl]-3-methylpenta-2,4-dienoic acid | 8 |
| BWQ | ~{tert}-butyl 3-[(2~{S},5~{S},8~{S})-14-cyclopentyloxy-2-(2-methylpropyl)-4,7-bis(oxidanylidene)-3,6,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,16}]heptadeca-1(10),11,13,15-tetraen-5-yl]propanoate | 8 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 8 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 7 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 6 |
| R1H | tariquidar | 6 |
| TTC | (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE | 6 |
| Y01 | CHOLESTEROL HEMISUCCINATE | 6 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 5 |
| FY5 | estrone 3-sulfate | 4 |
| KJ9 | (2R,5S,8S)-2,5-dihydroxy-5,10-dioxo-8-[(undecanoyloxy)methyl]-4,6,9-trioxa-5lambda~5~-phosphahenicosan-1-yl 3-deoxy-alpha-L-altro-oct-2-ulopyranosidonic acid | 4 |
| MIX | 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE | 4 |
| PLC | DIUNDECYL PHOSPHATIDYL CHOLINE | 4 |
| A1L26 | Pip2(20:4/18:0) | 3 |
| A1L27 | milbemycin oxime | 3 |
| JAA | {(1R,2R)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl}acetic acid | 3 |
| TPF | 2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL | 3 |
| BEF | BERYLLIUM TRIFLUORIDE ION | 2 |
| D6T | ~{N}-[5-[1-[4-[2-[6-methoxy-7-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-3,4-dihydro-1~{H}-isoquinolin-2-yl]ethyl]phenyl]-1,2,3-triazol-4-yl]-2-propanoyl-phenyl]quinoline-2-carboxamide | 2 |